Ivosidenib (AG-120)

ivosidenib · Agios Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ivosidenib (AG-120), covering 2025-05-18 to 2025-05-18. Get the full timeline:

Most recent: Clinical Trial Update: IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome [Phase 2]